 |
인쇄하기
취소
|
Hanmi, Sanofi-Aventis Korea announce partnership
Hanmi Pharmaceutical said yesterday that it has established a marketing and distribution partnership with Sanofi-Aventis Korea.
Under the deal, Sanofi-Aventis Korea will be in charge of selling Hanmi’s combination drug (irbersartan/atorvastatin tablets) when Hanmi completes Phase III clinical trials and acquires a market authorization next year.
The individual domestic market size of irb...
Under the deal, Sanofi-Aventis Korea will be in charge of selling Hanmi’s combination drug (irbersartan/atorvastatin tablets) when Hanmi completes Phase III clinical trials and acquires a market authorization next year.
The individual domestic market size of irb...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.